(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide

Indinavir; LC-ESI-Q; MS; POS; 15 V, 30 V

Indinavir; LC-ESI-Q; MS; POS; 45 V

Indinavir; LC-ESI-Q; MS; POS; 60 V

Indinavir; LC-ESI-Q; MS; POS; 75 V, 90 V

Indinavir; LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+

Indinavir; LC-ESI-QFT; MS2; CE: 15; R=17500; [M-H]-

Indinavir; LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+

Indinavir; LC-ESI-QFT; MS2; CE: 30; R=17500; [M-H]-

Indinavir; LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+

Indinavir; LC-ESI-QFT; MS2; CE: 45; R=17500; [M-H]-

Indinavir; LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+

Indinavir; LC-ESI-QFT; MS2; CE: 60; R=17500; [M-H]-

Indinavir; LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+

Indinavir; LC-ESI-QFT; MS2; CE: 75; R=17500; [M-H]-

Indinavir; LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+

Indinavir; LC-ESI-QFT; MS2; CE: 90; R=17500; [M-H]-